Wcg Wealth Advisors LLC Entrada Therapeutics, Inc. Transaction History
Wcg Wealth Advisors LLC
- $1.42 Billion
- Q4 2024
A detailed history of Wcg Wealth Advisors LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Wcg Wealth Advisors LLC holds 24,030 shares of TRDA stock, worth $217,231. This represents 0.03% of its overall portfolio holdings.
Number of Shares
24,030
Previous 22,624
6.21%
Holding current value
$217,231
Previous $362,000
14.64%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding TRDA
# of Institutions
103Shares Held
27.8MCall Options Held
40.3KPut Options Held
4.1K-
Baker Bros. Advisors LP New York, NY4.87MShares$44 Million0.93% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$39.9 Million33.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$39.6 Million60.89% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.9MShares$26.2 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X02.08MShares$18.8 Million0.02% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $284M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...